Provided by Tiger Trade Technology Pte. Ltd.

Abivax S.A.

115.95
-3.5100-2.94%
Pre-market: 115.16-0.7900-0.68%08:06 EDT
Volume:1.29M
Turnover:149.99M
Market Cap:10.09B
PE:-22.23
High:118.75
Open:117.80
Low:114.30
Close:119.46
52wk High:148.83
52wk Low:69.81
Shares:87.05M
Float Shares:76.46M
Volume Ratio:1.27
T/O Rate:1.69%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.2168
EPS(LYR):-5.6758
ROE:-157.07%
ROA:-44.65%
PB:20.27
PE(LYR):-20.43

Loading ...

Stocks to Watch: Strategy, Super Micro, Constellation Brands

Dow Jones
·
Jun 30

U.S. Research Roundup- Comcast, Honeywell Aerospace, Qualys

Reuters
·
Jun 30

Movement Alert|Abivax S.A. Rises 27.93% Overnight, Positive Phase 3 Maintenance Data Accelerates Safety Concern Recovery

Market Focus
·
Jun 30

Abivax Reports Positive Phase 3 Maintenance Data for Ulcerative Colitis Drug

MT Newswires Live
·
Jun 30

Movement Alert|Abivax S.A. Rises 21.37% in After-Hours Trading, Safety Controversy Digestion Fuels Rebound Momentum

Market Focus
·
Jun 30

Abivax announces results from ABTECT Maintenance Part 2

TIPRANKS
·
Jun 30

Abivax trading halted, news pending

TIPRANKS
·
Jun 30

NASDAQ Trade Halt Halt News Pending at 04:01 Pm

Reuters
·
Jun 30

European Equities Traded in the US as American Depositary Receipts Decline Friday

MT Newswires Live
·
Jun 26

Movement Alert|Abivax S.A. Rises 5.48% in Regular Trading, Bull-Bear Debate Intensifies Amid Phase 3 Trial Safety Controversy

Market Focus
·
Jun 26

Movement Alert|Abivax S.A. Falls 5.38% in After-Hours Trading, Phase 3 Trial Safety Controversy Continues to Suppress Rebound Momentum

Market Focus
·
Jun 26

Movement Alert|Abivax S.A. Falls 5.62% in Regular Trading, Phase 3 Trial Safety Concerns Continue to Suppress Rebound Momentum

Market Focus
·
Jun 26

Movement Alert|Abivax S.A. Overnight Decline 5.84%, Phase 3 Trial Safety Controversy Continues to Suppress Rebound

Market Focus
·
Jun 25

Movement Alert|Abivax S.A. Falls 5.15% in Regular Trading, Phase 3 Trial Safety Controversy Stalls Recovery Momentum

Market Focus
·
Jun 24

Abivax Sa : Jefferies Raises Target Price to $108 From $90

THOMSON REUTERS
·
Jun 22

U.S. RESEARCH ROUNDUP-Baldwin Insurance Group, Diamondback Energy, Visteon

Reuters
·
Jun 22

Movement Alert|Abivax S.A. Rises 5.15% in Regular Trading, Technical Rebound Continues as Phase 3 Safety Concerns Are Digested

Market Focus
·
Jun 17

Abivax SA Sponsored ADR (ABVX) Gets a Buy from Guggenheim

TIPRANKS
·
Jun 16

Analysts Are Bullish on These Healthcare Stocks: Encompass Health (EHC), Abivax SA Sponsored ADR (ABVX)

TIPRANKS
·
Jun 16

Barclays Keeps Their Buy Rating on Abivax SA Sponsored ADR (ABVX)

TIPRANKS
·
Jun 16